Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...

The US is making plans to try to intercept a fleeing oil tanker that Russia has claimed jurisdiction over, according to four people familiar with the matter, setting up a possible confrontation ...

The CIA conducted the first known U.S. attack on Venezuelan territory when it carried out a drone strike on a port facility in Venezuela last week, a government official familiar with the operation ...

3I/ATLAS has passed its closest point to Earth, meaning we will soon lose sight of it for good. Some scientists want to send a spacecraft to chase down the alien comet — or the next interstellar ...

Gradient Ventures has spun out of Google to better position itself to win deals in the fast-moving early-stage AI market, according to people familiar with the situation. Gradient Ventures is now ...

U.S. fighter jets scrambled Wednesday to intercept four Russian warplanes off the coast of Alaska, the North American Aerospace Defense Command (NORAD) said Thursday. NORAD said in a statement it ...

U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...

A federal judge in San Francisco on Wednesday temporarily blocked a federal administrative subpoena aimed at unmasking Instagram accounts that named and shamed a Border Patrol agent who was part of ...

While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.

Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.

Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...